advisorsecurities master

SEPNSepterna, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
21495
Ticker
SEPN
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2024-10-25
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
SEPN

Detail

Enriched 2026-08-14 20:47

Market cap
$2,249,362,075.93
Shares outstanding (class)
45,075,533
Shares outstanding (weighted)
46,676,947
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
130
Location
SOUTH SAN FRANCISCO, CA
Description

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data